Studying mice and tissue samples from the arteries of patients with atherosclerosis, researchers at Washington University School of Medicine in St. Louis suggest this plaque accumulation is driven, at least in part, by processes similar to the plaque formation implicated in brain diseases such Alzheimer’s and Parkinson’s.
A deficiency of vitamin D has been linked to Type 2 diabetes and heart disease, two illnesses that commonly occur together and are the most common cause of illness and death in Western countries. Now, new research in mice led by the School of Medicine’s Carlos Bernal-Mizrachi suggests vitamin D plays a major role in preventing the inflammation that leads to Type 2 diabetes and atherosclerosis.
Burning biomass for cooking and heating, a common practice of rural people in developing countries, has been linked to an increase in cardiovascular problems.
A new study raises the intriguing possibility that drugs prescribed to lower cholesterol may be effective against macular degeneration, a blinding eye disease. Researchers at Washington University School of Medicine in St. Louis have found that age-related macular degeneration shares a common link with atherosclerosis. Both problems have the same underlying defect: the inability to remove a buildup of fat and cholesterol.
People with diabetes often develop clogged arteries that cause heart disease. New research at Washington University School of Medicine in St. Louis has found that when vitamin D levels are adequate in people with diabetes, blood vessels are less likely to clog. But in patients with insufficient vitamin D, immune cells bind to blood vessels near the heart, then trap cholesterol to block those blood vessels.
Researchers at Washington University School of Medicine in St. Louis have found that problems with a digestive process in cells can clog arteries. The finding could provide a target for future therapies aimed at preventing or reversing atherosclerosis.
Artery-opening brain stents designed to reduce high risk of repeat strokes instead significantly increased strokes and deaths, results of a multi-center clinical trial show.
Scientists at Washington University School of Medicine in St. Louis have found a way to significantly reduce atherosclerosis in mice that does not involve lowering cholesterol levels or eliminating other obesity-related problems. Atherosclerosis is the process through which fatty substances, such as cholesterol and cellular waste products accumulate in the lining of arteries. The research team inhibited atherosclerosis in the mice by interfering with production of a substance called fatty acid synthase, an enzyme that converts dietary sugars into fatty acids in the liver.